{
    "title": "A shot in the arm for drug giants: AstraZeneca and GlaxoSmithKline reveal success on lucrative new treatments",
    "url": "https://www.dailymail.co.uk/money/markets/article-3305649/A-shot-arm-drug-giants-AstraZeneca-GlaxoSmithKline-reveal-success-lucrative-new-treatments.html",
    "date": "2015-11-05",
    "keywords": [
        "gsk",
        "approval",
        "year",
        "drug",
        "glaxosmithkline",
        "treatment",
        "research",
        "development",
        "astrazeneca",
        "breakthrough",
        "asthma",
        "executive",
        "soriot",
        "exclusivity",
        "respiratory",
        "drugmaker",
        "quarter",
        "share",
        "pfizer",
        "cancer",
        "expiry",
        "investment",
        "yesterday",
        "blockbuster",
        "horizonin",
        "medicationand",
        "revenue",
        "line",
        "city",
        "medicine",
        "regulatorsbalance",
        "patent",
        "cliff",
        "protection",
        "generic",
        "copycatsastra",
        "heartburn",
        "franchise",
        "medicinesapproval",
        "nucala",
        "sir",
        "space",
        "evidence",
        "jump",
        "shire",
        "slide",
        "article",
        "week",
        "intention",
        "growth",
        "merger",
        "wouldnt",
        "giant",
        "takeover",
        "approach",
        "astra",
        "decision",
        "lupus",
        "heart",
        "phase",
        "ii",
        "second",
        "yearthe",
        "news",
        "core",
        "cent",
        "drugsthe",
        "resurgence",
        "brilinta",
        "performance",
        "optimism",
        "glennie"
    ],
    "category": [
        "money",
        "markets"
    ]
}